Carestream’s Vue Motion Cleared for Mobile Reading
Carestream Health received FDA clearance for use of its Vue Motion image view for clinical X-ray reading on mobile devices.
The approval covers reading - not just viewing - on iPhone 4s, iPad 2, Galaxy Note and Galaxy S III mobile devices, the company announced.
“Diagnostic review of X-ray images with mobile devices can expedite patient treatment decisions and enable better collaboration, which can ultimately help enhance patient care,” Neville Skudowitz, Carestream’s global product director for healthcare information solutions, said in a statement.
Carestream recommends that during diagnostic image review, radiology professions frequently and concurrently use Vue Motion viewing tools, such as zoom, pan, and window level adjustments. This will help maximize image contrast and detail sharpness of each image displayed using Vue Motion on portable and mobile devices, according to the company.
How to Successfully Launch a CCTA Program at Your Hospital or Practice
June 11th 2025Emphasizing increasing recognition of the capability of coronary computed tomography angiography (CCTA) for the evaluation of acute and stable chest pain, this author defuses common misperceptions and reviews key considerations for implementation of a CCTA program.
New PSMA PET Prep Product Now Available in the U.S.
June 11th 2025Offering an extended shelf life, the FDA-approved Gozellix, a preparation kit for gallium-68 (68Ga) gozetotide injection, is indicated for use in PSMA PET imaging of prostate cancer patients with suspected recurrence or metastasis.
